SEP 17, 2016 08:56 AM PDT

Inhibiting the Autoimmune Response to Treat Multiple Sclerosis

WRITTEN BY: Kara Marker
Treatment options for autoimmune diseases like multiple sclerosis (MS) are complicated, because inhibiting the immune system to prevent neural damage simultaneously makes the patient extremely vulnerable to dangerous infections. New research from the University of Maryland aims to bypass the negative side effects while still inhibiting the autoimmune response that leads to the debilitating fatigue, disturbed sensation, and mobility problems associated with MS.
In the words of corresponding author and assistant professor Christopher Jewell, their aim is to “reprogram how the immune system responds to self-cells in the brain that are mistakenly attacked during MS.”

For MS, type 1 diabetes, and other autoimmune diseases with no existing cure, the Maryland scientists present a combination of immunology and nanotechnology that could inhibit the autoimmune responses that causes disease and leave the healthy function of the immune system up and running. 

Together, the team of scientists created biodegradable polymers that deliver regulatory signals to the lymph nodes upon injection, prompting the immune organs to produce regulatory immune cells as opposed to autoimmune cells that attack myelin, the insulator and protector of neurons in the brain. 

“The hope is that these cells can directly suppress inflammation without targeting healthy immune function,” said first author Lisa Tostanoski. The team saw initial success in polymer delivery in both cell models and pre-clinical animal models of MS: they demonstrated that a single treatment of biodegradable particles could completely and permanently reverse paralysis from MS.

"This innovative research has the potential to open up a new, highly selective approach to treating multiple sclerosis," said Bruce F. Bebo, Ph.D., Executive Vice President of Research at the National Multiple Sclerosis Society, which funded the Maryland study.

MS affects more than two million people across the globe, with symptoms ranging from mild to complete paralysis. 

The study was recently published in the journal Cell Reports.
 


Sources: National Multiple Sclerosis Society, University of Maryland
Images: nutriunify.com, www.kevinmd.com
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Children and Adolescents
Myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS), is a disabling condition that affects every aspect of a person’s life. In the U. S.,...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Can a Low-Carb Diet Treat Osteoarthritis?
A pilot study suggests it might. Researchers at the University of Alabama, Birmingham, found that a low-carbohydrate diet was able to reduce pain intensity...
SEP 17, 2019
Immunology
SEP 17, 2019
The Morel of the Story
It’s morel mushroom season in the United States and it promises to be a good one! Plenty of rain and warmth favor the growth of this delicatessen, bu...
SEP 17, 2019
Microbiology
SEP 17, 2019
How a Parasitic Amoeba Evades the Immune System
A parasitic amoeba that causes a gut disease can nibble on host cells and use their proteins. (Image courtesy UC Davis/Hannah Miller)...
SEP 17, 2019
Health & Medicine
SEP 17, 2019
Fourth-Generation Rapid Diagnostic Tests for Acute HIV-1 Infections
The ability to diagnose an acute HIV-1 infection before there are detectable antibodies to HIV 1/2 is critical to making an early diagnosis and getting the...
SEP 17, 2019
Cancer
SEP 17, 2019
How cancer tricks our immune systems
Research published yesterday in Nature details the finding of a new “Don’t eat me” signal that cancers use to hide from the body’s ...
Loading Comments...